Site icon pharmaceutical daily

Kraig Biocraft Laboratories Expands Production Footprint in Vietnam

Kraig Labs signs factory lease to expand production capacity

ANN ARBOR, Mich.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24KBLB&src=ctag" target="_blank"gt;$KBLBlt;/agt; lt;a href="https://twitter.com/hashtag/KBLB?src=hash" target="_blank"gt;#KBLBlt;/agt;–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading
developer of spider silk based fibers, announced today that, through its
subsidiary Prodigy Textiles, the Company has signed a new 5 year lease
on a factory, expanding its production footprint in Vietnam. The roughly
50,000 ft2 facility in Quang Nam province is expected to play
a major role in supporting the Company’s increasing production capacity
of its proprietary recombinant spider silk technologies.

“Our team in Vietnam, led by Mr. Kenneth Le, has done an excellent job
of scouting, selecting, and negotiating the terms of this deal. With its
close proximity to the necessary mulberry fields, and easy access to
shipping ports, this facility will serve as a springboard for Kraig
Labs’ introduction of spider silk into the global textile markets,” said
COO Jon Rice.

The Company expects to begin transferring its technology into the larger
factory from the temporary facility that Prodigy Textiles has been
utilizing since December of 2018.

To view the most recent news from Kraig Labs and/or to sign up for
Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com),
a reporting biotechnology company, is the leading developer of
genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global textile
industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and
expectations other than historical facts are “forward-looking
statements.” These statements are made on the basis of management’s
current views and assumptions. As a result, there can be no assurance
that management’s expectations will necessarily come to pass. These
forward-looking statements generally can be identified by phrases such
as “believes,” “plans,” “expects,” “anticipates,” “foresees,”
“estimated,” “hopes,” “if,” “develops,” “researching,” “research,”
“pilot,” “potential,” “could” or other words or phrases of similar
import. Forward looking statements include descriptions of the Company’s
business strategy, outlook, objectives, plans, intentions and goals. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
those in forward-looking statements. This press release does not
constitute an offer to sell or the solicitation of an offer to buy any
security.

Contacts

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

Exit mobile version